产å“说明
应用
Acenocoumarol was used to study the role of P-glycoprotein in transport of oral vitamin K in Caco-2 cells and as an LC/MS standard.
Acenocoumarol has been used as a standard for the determination of coumarins in cosmetics.
包装
10, 50 mg in glass bottle
生化/生ç†ä½œç”¨
Acenocoumarol is effective against thromboembolic disorders.
Acenocoumarol is a warfarin analog, an anticoagulant that inhibits Vitamin K epoxide reductase. This results in depletion of the reduced form of vitamin K (vitamin KH2), limiting the gamma-carboxylation and subsequent activation of the vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S, resulting in decreased prothrombin levels and the amount of thrombin generated.
特点和优势
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
基本信æ¯
| ç»éªŒ(实验)分åå¼ | C19H15NO6 |
| 分åé‡ | 353.33 |
| EC å· | 205-807-3 |
| MDLç¼–å· | MFCD00137816 |
| PubChem化å¦ç‰©è´¨ç¼–å· | 329825137 |
| NACRES | NA.77 |
äº§å“æ€§è´¨
| 测定 | ≥98% (HPLC) |
| å½¢å¼ | powder |
| 颜色 | white to tan |
| 溶解性 | DMSO, heptane and xylene: ≥17 mg/mL |
| 创始人 | Novartis |
| å‚¨å˜æ¸©åº¦ | −20℃ |
| SMILES string | CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)C2=C(O)c3ccccc3OC2=O |
| InChI | 1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3 |
| InChI key | VABCILAOYCMVPS-UHFFFAOYSA-N |
| Gene Information | human ... VKORC1(79001) |
安全信æ¯
| 象形图 |  |
| è¦ç¤ºç”¨è¯ï¼š | Warning |
| å±é™©å£°æ˜Ž | H302 - H315 - H319 - H335 |
| 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
| å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| é¶å™¨å®˜ | Respiratory system |
| 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |